Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Budoff MJ, Bhatt DL, Kinninger A, Lakshmanan S, Muhlestein JB, Le VT, May HT, Shaikh K, Shekar C, Roy SK, Tayek J, Nelson JR. Budoff MJ, et al. Among authors: muhlestein jb. Eur Heart J. 2020 Oct 21;41(40):3925-3932. doi: 10.1093/eurheartj/ehaa652. Eur Heart J. 2020. PMID: 32860032 Free PMC article. Clinical Trial.
Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients.
Allen Maycock CA, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Pearson RR, Li Q, Anderson JL; Intermountain Heart Collaborative Study. Allen Maycock CA, et al. Among authors: muhlestein jb. J Am Coll Cardiol. 2002 Nov 20;40(10):1777-85. doi: 10.1016/s0735-1097(02)02477-4. J Am Coll Cardiol. 2002. PMID: 12446061 Free article.
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease.
Horne BD, Muhlestein JB, Carlquist JF, Bair TL, Madsen TE, Hart NI, Anderson JL; Intermountain Heart Collaborative (IHC) Study Group. Horne BD, et al. Among authors: muhlestein jb. Circulation. 2003 Jan 21;107(2):258-63. doi: 10.1161/01.cir.0000045668.71683.92. Circulation. 2003. PMID: 12538425
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.
Muhlestein JB, May HT, Jensen JR, Horne BD, Lanman RB, Lavasani F, Wolfert RL, Pearson RR, Yannicelli HD, Anderson JL. Muhlestein JB, et al. J Am Coll Cardiol. 2006 Jul 18;48(2):396-401. doi: 10.1016/j.jacc.2006.05.009. Epub 2006 May 24. J Am Coll Cardiol. 2006. PMID: 16843192 Free article. Clinical Trial.
305 results